Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Soares (Leicester, United Kingdom), H. Koca (Gothenburg, Sweden), A. Olin (Gothenburg, Sweden), S. Siddiqui (Leicester, United Kingdom). Repeatabillity of PExA SPA and albumin as small airways dysfunction candidate biomarkers in Asthma.. 4451

Member's Comments

No comment yet.

Related content which might interest you: Concentration of exhaled endogenous particles in relation to peripheral airway dysfunction Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Association between airway bacterial abundance and urinary inflammatory biomarkers in COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Association between airway inflammation, disease control and lung function parameters in asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Clinical relevance of small airways assessment by lung function tests in asthma Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Non-invasive urinary lipid mediator excretion profiles identify sub-phenotypes of asthma in the U-BIOPRED study Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 The combination of elevated FeNO and blood eosinophils relate to reduced lung function and increased bronchial responsiveness in young asthmatics Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Small airway function in smokers without airway obstruction Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Clinical implications of small airways dysfunction in COPD Source: International Congress 2017 – From small airways dysfunction to dyspnoea in COPD: from physiology to clinical application Year: 2017 Small airways function in children with mild asthma and normal FEV1 Source: Annual Congress 2013 –New perspectives of lung function assessment in children Year: 2013 Small airway dysfunction is associated to the excessive bronchoconstriction in asthma Source: International Congress 2014 – Lung function testing: new findings and new approaches Year: 2014 LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Lung clearance index is a reliable and sensitive measure of airways disease in bronchiectasis Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012 Diagnosis of small airways dysfunction in patients with asthma. Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020 Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014